VITAMIN
E
WHERE
DO
WE
STAND
I
PROPOSE
THAT
CLINICIANS
SHOULD
HAVE
A
GENERAL
UNDERSTANDING
OF
WHAT
LITTLE
PHYSIOLOGY
IS
KNOWN
ABOUT
TOCOPHEROL
BE
ABLE
TO
RECOGNIZE
THE
CIRCUMSTANCES
THAT
CAUSE
LOW
TOCOPHEROL
LEVELS
UNDERSTAND
WHEN
TO
PROVIDE
PHYSIOLOGIC
REPLACEMENT
THERAPY
AND
ACCEPT
THE
RESPONSIBILITY
FOR
PROTECTING
THEIR
PATIENTS
FROM
UNCONTROLLED
EXPERIMENTAL
USE
OF
TOCOPHEROLS
TOCOPHEROL
PHYSIOLOGY
TOCOPHEROL
PHARMACOLOGY
TOCOPHEROL
DEFICIENCY
THERAPY
IN
DEFICIENCY
STATES
AND
PHARMACOLOGICAL
DOSES
OF
TOCOPHEROL
ARE
DISCUSSED
PATIENTS
WITH
PROLONGED
FAT
MALABSORPTION
AND
SOME
PREMATURE
INFANTS
RECEIVING
IRON
MUST
BE
GIVEN
VITAMIN
E
USE
OF
TOCOPHEROL
THERAPY
IN
BRONCHOPULMONARY
DYSPLASIA
AND
RETROLENTAL
FIBROPLASIA
WHILE
PROMISING
IS
UNPROVEN
AND
SHOULD
BE
USED
ONLY
IN
A
CONTROLLED
STUDY
RESEARCH
ON
THE
ROLE
OF
VITAMIN
E
IN
HUMAN
PHYSIOLOGY
IS
ENTERING
A
RAPIDGROWTH
PHASE
